sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Biologics Targeting CCR4 Market Growth 2023-2029

Global Biologics Targeting CCR4 Market Growth 2023-2029

Home / Categories / Healthcare
Global Biologics Targeting CCR4 Market Growth 2023-2029
Global Biologics Targeting CCR4 Market...
Report Code
RO1/138/1003

Publish Date
13/May/2024

Pages
200
PRICE
$ 2800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 3400/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 4400/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
List of Tables
Table 1. Biologics Targeting CCR4 Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biologics Targeting CCR4 Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Small Molecule Chemicals
Table 5. Global Biologics Targeting CCR4 Sales by Type (2018-2023) & (K Units)
Table 6. Global Biologics Targeting CCR4 Sales Market Share by Type (2018-2023)
Table 7. Global Biologics Targeting CCR4 Revenue by Type (2018-2023) & ($ million)
Table 8. Global Biologics Targeting CCR4 Revenue Market Share by Type (2018-2023)
Table 9. Global Biologics Targeting CCR4 Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Biologics Targeting CCR4 Sales by Application (2018-2023) & (K Units)
Table 11. Global Biologics Targeting CCR4 Sales Market Share by Application (2018-2023)
Table 12. Global Biologics Targeting CCR4 Revenue by Application (2018-2023)
Table 13. Global Biologics Targeting CCR4 Revenue Market Share by Application (2018-2023)
Table 14. Global Biologics Targeting CCR4 Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Biologics Targeting CCR4 Sales by Company (2018-2023) & (K Units)
Table 16. Global Biologics Targeting CCR4 Sales Market Share by Company (2018-2023)
Table 17. Global Biologics Targeting CCR4 Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Biologics Targeting CCR4 Revenue Market Share by Company (2018-2023)
Table 19. Global Biologics Targeting CCR4 Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Biologics Targeting CCR4 Producing Area Distribution and Sales Area
Table 21. Players Biologics Targeting CCR4 Products Offered
Table 22. Biologics Targeting CCR4 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biologics Targeting CCR4 Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Biologics Targeting CCR4 Sales Market Share Geographic Region (2018-2023)
Table 27. Global Biologics Targeting CCR4 Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Biologics Targeting CCR4 Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Biologics Targeting CCR4 Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Biologics Targeting CCR4 Sales Market Share by Country/Region (2018-2023)
Table 31. Global Biologics Targeting CCR4 Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Biologics Targeting CCR4 Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Biologics Targeting CCR4 Sales by Country (2018-2023) & (K Units)
Table 34. Americas Biologics Targeting CCR4 Sales Market Share by Country (2018-2023)
Table 35. Americas Biologics Targeting CCR4 Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Biologics Targeting CCR4 Revenue Market Share by Country (2018-2023)
Table 37. Americas Biologics Targeting CCR4 Sales by Type (2018-2023) & (K Units)
Table 38. Americas Biologics Targeting CCR4 Sales by Application (2018-2023) & (K Units)
Table 39. APAC Biologics Targeting CCR4 Sales by Region (2018-2023) & (K Units)
Table 40. APAC Biologics Targeting CCR4 Sales Market Share by Region (2018-2023)
Table 41. APAC Biologics Targeting CCR4 Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Biologics Targeting CCR4 Revenue Market Share by Region (2018-2023)
Table 43. APAC Biologics Targeting CCR4 Sales by Type (2018-2023) & (K Units)
Table 44. APAC Biologics Targeting CCR4 Sales by Application (2018-2023) & (K Units)
Table 45. Europe Biologics Targeting CCR4 Sales by Country (2018-2023) & (K Units)
Table 46. Europe Biologics Targeting CCR4 Sales Market Share by Country (2018-2023)
Table 47. Europe Biologics Targeting CCR4 Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Biologics Targeting CCR4 Revenue Market Share by Country (2018-2023)
Table 49. Europe Biologics Targeting CCR4 Sales by Type (2018-2023) & (K Units)
Table 50. Europe Biologics Targeting CCR4 Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Biologics Targeting CCR4 Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Biologics Targeting CCR4 Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Biologics Targeting CCR4 Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Biologics Targeting CCR4 Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Biologics Targeting CCR4 Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Biologics Targeting CCR4
Table 58. Key Market Challenges & Risks of Biologics Targeting CCR4
Table 59. Key Industry Trends of Biologics Targeting CCR4
Table 60. Biologics Targeting CCR4 Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Biologics Targeting CCR4 Distributors List
Table 63. Biologics Targeting CCR4 Customer List
Table 64. Global Biologics Targeting CCR4 Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Biologics Targeting CCR4 Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Biologics Targeting CCR4 Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Biologics Targeting CCR4 Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Biologics Targeting CCR4 Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Biologics Targeting CCR4 Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Biologics Targeting CCR4 Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Biologics Targeting CCR4 Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Biologics Targeting CCR4 Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Biologics Targeting CCR4 Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Biologics Targeting CCR4 Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Biologics Targeting CCR4 Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Biologics Targeting CCR4 Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Biologics Targeting CCR4 Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Kyowa Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 79. Kyowa Biologics Targeting CCR4 Product Portfolios and Specifications
Table 80. Kyowa Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Kyowa Main Business
Table 82. Kyowa Latest Developments
Table 83. RAPT Therapeutics, Inc Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 84. RAPT Therapeutics, Inc Biologics Targeting CCR4 Product Portfolios and Specifications
Table 85. RAPT Therapeutics, Inc Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. RAPT Therapeutics, Inc Main Business
Table 87. RAPT Therapeutics, Inc Latest Developments
Table 88. Hanmi Pharmaceutical Co., Ltd Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 89. Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
Table 90. Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Hanmi Pharmaceutical Co., Ltd Main Business
Table 92. Hanmi Pharmaceutical Co., Ltd Latest Developments
Table 93. Eight Plus One Pharmaceutical Co Ltd Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 94. Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
Table 95. Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Eight Plus One Pharmaceutical Co Ltd Main Business
Table 97. Eight Plus One Pharmaceutical Co Ltd Latest Developments
LIST OF FIGURE
List of Figures
Figure 1. Picture of Biologics Targeting CCR4
Figure 2. Biologics Targeting CCR4 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologics Targeting CCR4 Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Biologics Targeting CCR4 Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biologics Targeting CCR4 Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Small Molecule Chemicals
Figure 11. Global Biologics Targeting CCR4 Sales Market Share by Type in 2022
Figure 12. Global Biologics Targeting CCR4 Revenue Market Share by Type (2018-2023)
Figure 13. Biologics Targeting CCR4 Consumed in S?zary Syndrome
Figure 14. Global Biologics Targeting CCR4 Market: S?zary Syndrome (2018-2023) & (K Units)
Figure 15. Biologics Targeting CCR4 Consumed in Mycosis Fungoides
Figure 16. Global Biologics Targeting CCR4 Market: Mycosis Fungoides (2018-2023) & (K Units)
Figure 17. Global Biologics Targeting CCR4 Sales Market Share by Application (2022)
Figure 18. Global Biologics Targeting CCR4 Revenue Market Share by Application in 2022
Figure 19. Biologics Targeting CCR4 Sales Market by Company in 2022 (K Units)
Figure 20. Global Biologics Targeting CCR4 Sales Market Share by Company in 2022
Figure 21. Biologics Targeting CCR4 Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Biologics Targeting CCR4 Revenue Market Share by Company in 2022
Figure 23. Global Biologics Targeting CCR4 Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Biologics Targeting CCR4 Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Biologics Targeting CCR4 Sales 2018-2023 (K Units)
Figure 26. Americas Biologics Targeting CCR4 Revenue 2018-2023 ($ Millions)
Figure 27. APAC Biologics Targeting CCR4 Sales 2018-2023 (K Units)
Figure 28. APAC Biologics Targeting CCR4 Revenue 2018-2023 ($ Millions)
Figure 29. Europe Biologics Targeting CCR4 Sales 2018-2023 (K Units)
Figure 30. Europe Biologics Targeting CCR4 Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Biologics Targeting CCR4 Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Biologics Targeting CCR4 Revenue 2018-2023 ($ Millions)
Figure 33. Americas Biologics Targeting CCR4 Sales Market Share by Country in 2022
Figure 34. Americas Biologics Targeting CCR4 Revenue Market Share by Country in 2022
Figure 35. Americas Biologics Targeting CCR4 Sales Market Share by Type (2018-2023)
Figure 36. Americas Biologics Targeting CCR4 Sales Market Share by Application (2018-2023)
Figure 37. United States Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Biologics Targeting CCR4 Sales Market Share by Region in 2022
Figure 42. APAC Biologics Targeting CCR4 Revenue Market Share by Regions in 2022
Figure 43. APAC Biologics Targeting CCR4 Sales Market Share by Type (2018-2023)
Figure 44. APAC Biologics Targeting CCR4 Sales Market Share by Application (2018-2023)
Figure 45. China Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Biologics Targeting CCR4 Sales Market Share by Country in 2022
Figure 53. Europe Biologics Targeting CCR4 Revenue Market Share by Country in 2022
Figure 54. Europe Biologics Targeting CCR4 Sales Market Share by Type (2018-2023)
Figure 55. Europe Biologics Targeting CCR4 Sales Market Share by Application (2018-2023)
Figure 56. Germany Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Biologics Targeting CCR4 Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Application (2018-2023)
Figure 65. Egypt Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Biologics Targeting CCR4 Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Biologics Targeting CCR4 in 2022
Figure 71. Manufacturing Process Analysis of Biologics Targeting CCR4
Figure 72. Industry Chain Structure of Biologics Targeting CCR4
Figure 73. Channels of Distribution
Figure 74. Global Biologics Targeting CCR4 Sales Market Forecast by Region (2024-2029)
Figure 75. Global Biologics Targeting CCR4 Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Biologics Targeting CCR4 Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Biologics Targeting CCR4 Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Biologics Targeting CCR4 Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Biologics Targeting CCR4 Revenue Market Share Forecast by Application (2024-2029)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com